Abstract
Pediatric Blood & CancerVolume 68, Issue 11 e29278 COMMENTARY When it comes to drug access, should children be considered small adults? Countering coverage denials of FLT3 inhibitors in children with FLT3-ITD AML Tristan E. Knight, Corresponding Author Tristan E. Knight knight.tristan@gmail.com orcid.org/0000-0002-7828-1522 Division of Hematology/Oncology, Department of Pediatrics, The Hospital for Sick Children (SickKids) and the University of Toronto, Toronto, Ontario, Canada Correspondence Tristan Knight, The Hospital for Sick Children (SickKids), Pediatric Hematology & Oncology, 555 University Ave, Toronto, ON, Canada M5G 1X8. Email: knight.tristan@gmail.comSearch for more papers by this authorYubin Ge, Yubin Ge Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan, USA Molecular Therapeutics Program, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan, USASearch for more papers by this authorJeffrey W. Taub, Jeffrey W. Taub orcid.org/0000-0003-2228-3235 Division of Hematology/Oncology, Children's Hospital of Michigan, Detroit, Michigan, USA Department of Pediatrics, Wayne State University School of Medicine, Detroit, Michigan, USA Department of Pediatrics, Central Michigan University, Mt. Pleasant, Michigan, USASearch for more papers by this authorJohann Hitzler, Johann Hitzler orcid.org/0000-0003-1158-186X Division of Hematology/Oncology, Department of Pediatrics, The Hospital for Sick Children (SickKids) and the University of Toronto, Toronto, Ontario, Canada Developmental and Stem Cell Biology, The Hospital for Sick Children Research Institute, Toronto, Ontario, CanadaSearch for more papers by this authorJoerg Krueger, Joerg Krueger Division of Hematology/Oncology, Department of Pediatrics, The Hospital for Sick Children (SickKids) and the University of Toronto, Toronto, Ontario, CanadaSearch for more papers by this author Tristan E. Knight, Corresponding Author Tristan E. Knight knight.tristan@gmail.com orcid.org/0000-0002-7828-1522 Division of Hematology/Oncology, Department of Pediatrics, The Hospital for Sick Children (SickKids) and the University of Toronto, Toronto, Ontario, Canada Correspondence Tristan Knight, The Hospital for Sick Children (SickKids), Pediatric Hematology & Oncology, 555 University Ave, Toronto, ON, Canada M5G 1X8. Email: knight.tristan@gmail.comSearch for more papers by this authorYubin Ge, Yubin Ge Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan, USA Molecular Therapeutics Program, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan, USASearch for more papers by this authorJeffrey W. Taub, Jeffrey W. Taub orcid.org/0000-0003-2228-3235 Division of Hematology/Oncology, Children's Hospital of Michigan, Detroit, Michigan, USA Department of Pediatrics, Wayne State University School of Medicine, Detroit, Michigan, USA Department of Pediatrics, Central Michigan University, Mt. Pleasant, Michigan, USASearch for more papers by this authorJohann Hitzler, Johann Hitzler orcid.org/0000-0003-1158-186X Division of Hematology/Oncology, Department of Pediatrics, The Hospital for Sick Children (SickKids) and the University of Toronto, Toronto, Ontario, Canada Developmental and Stem Cell Biology, The Hospital for Sick Children Research Institute, Toronto, Ontario, CanadaSearch for more papers by this authorJoerg Krueger, Joerg Krueger Division of Hematology/Oncology, Department of Pediatrics, The Hospital for Sick Children (SickKids) and the University of Toronto, Toronto, Ontario, CanadaSearch for more papers by this author First published: 06 August 2021 https://doi.org/10.1002/pbc.29278Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Volume68, Issue11November 2021e29278 RelatedInformation
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
